Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
34.03 USD +16.22% Intraday chart for Protagonist Therapeutics, Inc. +22.10% +48.41%
May. 07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bullish

Bullish

Bullish

Resistance 36.08 36.08 45.82
Spread/Res.-5.68%-5.68%-25.73%
Spread/Supp.+16.82%+38.00%+56.17%
Support 29.13 24.66 21.79

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Charts Protagonist Therapeutics, Inc.